Apyx Medical
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $11,487 | $12,149 | $14,539 | $14,662 |
Gross Profit | 2,421 | 2,811 | 5,949 | 4,062 |
EBITDA | -3,089 | -4,953 | -5,984 | -8,269 |
EBIT | -3,233 | -5,109 | -6,141 | -8,421 |
Net Income | -4,703 | -6,556 | -7,576 | -9,607 |
Net Change In Cash | 11,487 | 12,149 | 14,539 | 14,662 |
Free Cash Flow | -4,593 | -4,618 | -6,376 | -551 |
Cash | 28,013 | 32,677 | 37,282 | 43,652 |
Basic Shares | 34,644 | 34,644 | 34,644 | 34,644 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $52,349 | $44,510 | $48,517 | $27,711 |
Gross Profit | 14,122 | 29,131 | 33,601 | 17,504 |
EBITDA | -18,112 | -22,006 | -13,907 | -18,476 |
EBIT | -18,804 | -22,896 | -14,810 | -19,363 |
Net Income | -18,713 | -23,278 | -15,200 | -11,906 |
Net Change In Cash | 52,349 | 44,510 | 48,517 | 27,711 |
Cost of Revenue | -21,073 | -11,148 | -16,720 | |
Free Cash Flow | -5,782 | -21,290 | -11,172 | -16,647 |
Cash | 43,652 | 10,192 | 30,870 | 41,915 |
Basic Shares | 34,622 | 34,516 | 34,332 | 34,212 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.14 |
2024-06-30 | -$0.19 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.28 |
